Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Patrick Penttilä
Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Correlation of C-Met Expression and Outcome in Patients With Renal Cell Carcinoma Treated With Sunitinib
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Sunitinib-Associated Hypertension and Neutropenia as Efficacy Biomarkers in Metastatic Renal Cell Carcinoma Patients
British Journal of Cancer
Cancer Research
Oncology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma
Oncotarget
Oncology
Pcn94 - Cost-Effectiveness of Cabozantinib Versus Sunitinib or Pazopanib as First-Line Treatment of Patients With Advanced Renal Cell Carcinoma in the Uk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Oncologist
Cancer Research
Medicine
Oncology
A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma
Case Reports in Oncological Medicine
Oncology
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
